Advertisement
Advertisement
Retracef

Retracef

cefixime

Manufacturer:

ACME

Distributor:

Remed

Marketer:

Euro Generics
Concise Prescribing Info
Contents
Cefixime
Indications/Uses
Infections caused by cefixime-susceptible strains of Strep sp, Strep pneumoniae, Neisseria gonorrhoeae, Branhamella catarrhalis, E. coli, Klebsiella sp, Serratia sp, Proteus sp, H. influenzae: Bronchitis, bronchiectasis w/ infection, secondary infections of chronic resp tract disease, pneumonia; pyelonephritis, cystitis, gonococcal urethritis; cholecystitis, cholangitis; scarlet fever; otitis media & sinusitis.
Dosage/Direction for Use
Reconstitution: Add 22.5 mL of water. Adult & childn >10 yr 200-400 mg daily in 2 divided doses, weighing ≤30 kg 200-400 mg. Childn 11-12 yr 15 mL or 300 mg, 5-10 yr 10 mL or 200 mg daily, 1-4 yr 5 mL or 100 mg, 6 mth-1 yr 3.75 mL or 75 mg daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to cefixime, other cephalosporin antibiotics or penicillins. History of shocks. Personal or familial history of some form of allergy eg, bronchial asthma, rash & urticaria; serious renal function disorder; poor oral nutrition, therapy w/ parenteral nutrition. Elderly patients or those in a debilitated state. Careful observation as vit K deficiency symptoms may develop.
Special Precautions
Perform careful inquiry about any form of hypersensitivity prior to treatment. Sensitivity testing is recommended prior to antibiotic administration. Pregnancy. Safety has not been established in newborns & prematures.
Adverse Reactions
Diarrhea & stool changes. Nausea, abdominal pain, dyspepsia, vomiting, flatulence, headache & dizziness; rash, pruritus, urticaria, drug fever & arthralgia.
MIMS Class
Cephalosporins
ATC Classification
J01DD08 - cefixime ; Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
Presentation/Packing
Form
Retracef powd for oral susp 100 mg/5 mL
Packing/Price
37.5 mL x 1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement